NASDAQ:VOR | Free Cash Flow | Vor Biopharma Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$38.25M$48,000.00-$38.29M
2025-12-31-$22.8M$314,000.00-$23.12M-1.34%
2025-03-31-$31.07M$231,000.00-$31.3M
2024-12-31-$24.06M$72,000.00-$24.14M
2024-03-31-$30.47M$114,000.00-$30.58M
2023-12-31-$24.03M$111,000.00-$24.14M
2023-03-31-$24.27M$94,000.00-$24.36M
2022-12-31-$18.35M$321,000.00-$18.67M
2022-03-31-$22.9M$2.01M-$24.92M
2021-12-31-$17.59M$1.17M-$18.76M
2021-03-31-$17.65M$1.17M-$18.82M
2020-12-31-$13.63M$1.48M-$15.11M
2020-03-31-$6.09M$545,000.00-$6.63M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$142.71M$941,000.00-$143.65M
2024-12-31-$99.66M$229,000.00-$99.89M
2023-12-31-$100.29M$1.07M-$101.36M
2022-12-31-$85.14M$8.46M-$93.61M
2021-12-31-$69.14M$3.89M-$73.04M
2020-12-31-$36.29M$4.16M-$40.45M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.